United States & Marty Makary
16 shared events · Importance 9 · Last updated May 18, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States: The U.S. gains a new flu vaccine option, potentially improving public health outcomes for older adults.
Marty Makary: Makary, former FDA Commissioner, faced criticism for vaccine scrutiny and resigned amid controversies.
Aug 05, 2026 · 105 articles
Regulatory
United States: The United States, through the FDA, approved the drug, making it available to American patients and potentially influencing global regulatory decisions.
Marty Makary: Former FDA Commissioner Marty Makary initiated the Commissioner's National Priority Voucher Program, under which the drug was reviewed, contributing to the expedited approval.
Aug 26, 2026 · 92 articles
Business
United States: The United States is the primary market for the therapies and the regulatory environment is influenced by the Trump administration's executive order.
Marty Makary: Marty Makary, former FDA commissioner, commented on the FDA's regulatory actions supporting psychedelic therapeutics.
Jul 16, 2026 · 25 articles
Regulatory
Marty Makary: As Food and Drug Commissioner, Marty Makary signaled the administration's stance on saturated fats and commented on protein guidance.
Jan 07, 2026 · 7 articles
Regulatory
Marty Makary: As the Commissioner of the United States — Food and Drug Administration, Marty Makary is a key figure in implementing the new policy to reduce the number of required studies for drug approval, aiming to speed up drug development.
Feb 18, 2026 · 6 articles
International
Marty Makary: Marty Makary resigned as the head of the United States — Food and Drug Administration after a rocky tenure and complaints from various industry groups.
Apr 16, 2026 · 760 articles
International
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration due to difficulties and complaints from health industry executives, anti-abortion activists, and other Trump allies.
May 12, 2026 · 18 articles
Regulatory
Marty Makary: Marty Makary resigned as United States — Food and Drug Administration Commissioner, having engineered Tracy Beth Høeg's rapid rise and facing criticism from political allies.
May 15, 2026 · 17 articles
International
Marty Makary: Marty Makary resigned as the United States — Food and Drug Administration Commissioner, contributing to the agency's leadership upheavals.
May 12, 2026 · 17 articles
Domestic
Marty Makary: Marty Makary resigned as head of the United States — Food and Drug Administration, widening the leadership gap within the United States — United States Department of Health and Human Services and leaving behind unfinished initiatives.
May 13, 2026 · 6 articles
Domestic
Marty Makary: Marty Makary>>> resigned as Commissioner of the United States — Food and Drug Administration>>> after a tumultuous tenure marked by clashes with the Donald Trump>>> administration, industry, and public health groups. His departure creates uncertainty for several of his initiatives.
May 08, 2026 · 114 articles
International
Marty Makary: Marty Makary is resigning as the head of the United States — Food and Drug Administration after a rocky tenure, drawing complaints from various industry executives and activists.
Apr 30, 2026 · 116 articles
Regulatory
Marty Makary: Former United States — Food and Drug Administration Commissioner Marty Makary had indicated that reviewing the benefits of MDMA and other psychedelics was a top priority, though his resignation may impact the pace of review.
May 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Marty Makary interact across events, view sentiment trends, and discover connected entities.
Open Dashboard